Provided by Tiger Trade Technology Pte. Ltd.

AIM ImmunoTech Inc.

0.2584
+0.00532.09%
Post-market: 0.2567-0.0017-0.66%19:48 EDT
Volume:877.27K
Turnover:227.30K
Market Cap:7.87M
PE:-0.07
High:0.2700
Open:0.2631
Low:0.2540
Close:0.2531
52wk High:2.98
52wk Low:0.1901
Shares:30.44M
Float Shares:28.51M
Volume Ratio:0.71
T/O Rate:3.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9303
EPS(LYR):-30.8884
ROE:-2382.30%
ROA:-82.58%
PB:1.02
PE(LYR):-0.01

Loading ...

AIM ImmunoTech completes first dosing for final patient in Phase 2 DURIPANC pancreatic cancer trial

Reuters
·
Jun 18

AIM ImmunoTech - Duripanc Secondary Endpoint Analysis Expected to Begin June 2027

THOMSON REUTERS
·
Jun 18

AIM ImmunoTech - Files to Offer and Resell up to 13.08 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jun 18

Boku Tightens Capital Base with Treasury Share Buyback on AIM

TIPRANKS
·
Jun 18

Hargreave Hale AIM VCT Cuts Share Count with Buyback for Cancellation

TIPRANKS
·
Jun 17

Ouster, AIM Intelligent Machines Partner to Retrofit Heavy Machinery With AI Autonomy

MT Newswires Live
·
Jun 17

Hargreave Hale AIM VCT Declares Interim Dividend and Sets DRIS Deadline

TIPRANKS
·
Jun 17

Octopus AIM VCT posts profit, trims NAV as it reshapes dividend policy

TIPRANKS
·
Jun 17

Everyman Media weighs AIM delisting as strong trading lifts market share and cuts debt

TIPRANKS
·
Jun 16

Mendell Helium Debuts on AIM to Fund Expansion of Kansas Helium Assets

TIPRANKS
·
Jun 16

AIM ImmunoTech announces special shareholder meeting

Reuters
·
Jun 16

AIM ImmunoTech regains NYSE American compliance after addressing stockholders’ equity deficiency

Reuters
·
Jun 15

AIM ImmunoTech Regains Nyse American Compliance, Company Resolves Stockholder Equity Deficiency

THOMSON REUTERS
·
Jun 15

Restore cancels latest batch of share buybacks, trimming share count on AIM

TIPRANKS
·
Jun 15

Ascent Resources delays FY25 results, faces temporary AIM trading suspension

TIPRANKS
·
Jun 12

GCM Resources issues new shares to consultants and director ahead of AIM admission

TIPRANKS
·
Jun 12

Pri0r1ty Intelligence posts first-year results after AI-driven transformation and AIM trading resumption

TIPRANKS
·
Jun 12

AIM ImmunoTech Raises Capital via Registered Direct Offering

TIPRANKS
·
Jun 12

AIM ImmunoTech prices USD 2.65 million registered direct offering at USD 0.52 per share

Reuters
·
Jun 12

Boku Tightens Free Float With New Share Buybacks on AIM

TIPRANKS
·
Jun 11